• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 8, Issue 2
  3. Authors

Online ISSN: 2515-8260

Volume8, Issue2

Comparison of Pentraxin-3 (PTX-3), and Galectin-3 (GAL-3) with troponin I as biomarkers for early diagnosis of acute coronary syndrome

    Waleed H. Osman Ahmed ShawkyElserafy Shadia A. Fathy Marwa G.A. Hegazy Riham Abdel-Hamid Haroun

European Journal of Molecular & Clinical Medicine, 2021, Volume 8, Issue 2, Pages 2111-2123

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Background:Acute coronary syndrome (ACS) continues to be a leading cause of morbidity and mortality worldwide. Limited data on galectin-3 and pentraxin-3 are found as biomarkers in the ACS population. The objective of this study was to determine the variables that are most affected by high concentrations of pentraxin-3 (PTX-3) and galectin-3 (GAL-3), and the influence they have on outcomes of all-cause mortality in patients with ACS. Patients & Methods:One hundred and fifty patients with ST elevation myocardial infarction (STEMI) were included with 30 healthy subjects served as controls. Blood samples were drawn beforeprimary percutaneous coronary intervention (PCI) and after 12 and 48 hours. Critical changes in Troponine I as well as in PTX-3, GAL-3, lipid profile, CRP, RBS and cardiac enzymes markers were examined. Results:Highly significant time dependent increase in serum PTX-3 and Gal-3 was observed among acute STEMI patients when compared to controls. Troponin I, PXT-3, and GAL-3 showed high sensitivity and specificity in the prediction of Acute STEMI. Sensitivities of Troponin I, PXT-3, and GAL-3 were 96%, 90% and 94% respectively, while specificities were 85%, 85% and 85% respectively. Moreover, significant increase in Troponin I, LDH, AST, CK-total, CK-MB, CRP, RBS and lipid profile were observed among the acute STEMI patients as compared to controls.
Keywords:
    Acute coronary syndrome (ACS) Acute myocardial infarction (AMI) pentraxin-3 (PTX-3) galectin-3 (GAL-3)
  • PDF (322 K)
  • XML
(2021). Comparison of Pentraxin-3 (PTX-3), and Galectin-3 (GAL-3) with troponin I as biomarkers for early diagnosis of acute coronary syndrome. European Journal of Molecular & Clinical Medicine, 8(2), 2111-2123.
Waleed H. Osman; Ahmed ShawkyElserafy; Shadia A. Fathy; Marwa G.A. Hegazy; Riham Abdel-Hamid Haroun. "Comparison of Pentraxin-3 (PTX-3), and Galectin-3 (GAL-3) with troponin I as biomarkers for early diagnosis of acute coronary syndrome". European Journal of Molecular & Clinical Medicine, 8, 2, 2021, 2111-2123.
(2021). 'Comparison of Pentraxin-3 (PTX-3), and Galectin-3 (GAL-3) with troponin I as biomarkers for early diagnosis of acute coronary syndrome', European Journal of Molecular & Clinical Medicine, 8(2), pp. 2111-2123.
Comparison of Pentraxin-3 (PTX-3), and Galectin-3 (GAL-3) with troponin I as biomarkers for early diagnosis of acute coronary syndrome. European Journal of Molecular & Clinical Medicine, 2021; 8(2): 2111-2123.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 204
  • PDF Download: 244
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus